vs
Side-by-side financial comparison of ORGANIGRAM GLOBAL INC. (OGI) and Youxin Technology Ltd (YAAS). Click either name above to swap in a different company.
ORGANIGRAM GLOBAL INC. is the larger business by last-quarter revenue ($39.6K vs $39.4K, roughly 1.0× Youxin Technology Ltd). ORGANIGRAM GLOBAL INC. runs the higher net margin — -192.9% vs -324.8%, a 131.9% gap on every dollar of revenue.
Organigram Global Inc. is a leading Canadian producer of high-quality recreational and medical cannabis products. It offers a diverse portfolio of dried flower, edibles, vape products and pre-rolls, primarily serving the domestic Canadian market while expanding operations in select international markets including parts of Europe.
Youxin Technology Ltd is a China-based automotive digital service provider. It operates used car trading platforms, offers new car sales support, auto financing referrals, and after-sales resource matching for consumers and auto industry participants across mainland China, focusing on optimizing vehicle transaction efficiency.
OGI vs YAAS — Head-to-Head
Income Statement — Q3 FY2022 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.6K | $39.4K |
| Net Profit | $-76.5K | $-127.9K |
| Gross Margin | — | 67.9% |
| Operating Margin | -128.4% | — |
| Net Margin | -192.9% | -324.8% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-374.6K |
| Total Assets | — | $132.2K |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $-374.6K | ||
| Q2 22 | — | — |
| Q2 25 | — | $132.2K | ||
| Q2 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.2K | $-88.6K |
| Free Cash FlowOCF − Capex | $-19.9K | — |
| FCF MarginFCF / Revenue | -50.2% | — |
| Capex IntensityCapex / Revenue | 11.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $-88.6K | ||
| Q2 22 | $-15.2K | — |
| Q2 25 | — | — | ||
| Q2 22 | $-19.9K | — |
| Q2 25 | — | — | ||
| Q2 22 | -50.2% | — |
| Q2 25 | — | — | ||
| Q2 22 | 11.8% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGI
| Unrealized gain on changes in fair value of biological assets (Note 7) | $20.1K | 51% |
| Other | $19.6K | 49% |
YAAS
Segment breakdown not available.
